Biofil Chemicals & Pharmaceuticals Limited — Board Meeting, 11-02-2025: Outcome of Board Meeting

The Board of Directors of Biofil Chemicals and Pharmaceuticals Limited has approved the un-audited financial results for the quarter and nine months ended December 31, 2024. The total income reported is ₹14.22 crore, with a net profit of ₹1.65 crore. Additionally, the board confirmed the appointment of Mr. Meet Shah as a Promoter Non-Executive Director, canceled the agreement with Cyano Pharma for asset disposal, and proposed to sell leasehold land and other assets to related parties, pending member approval via postal ballot. The board also reviewed related party transaction policies.